本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tscan Therapeutics, Inc.

0.9885
-0.0415-4.03%
盘后0.9636-0.0249-2.52%19:43 EDT
成交量:45.79万
成交额:45.08万
市值:5,609.54万
市盈率:-0.99
高:1.02
开:1.02
低:0.9678
收:1.03
52周最高:2.57
52周最低:0.8824
股本:5,674.80万
流通股本:4,403.13万
量比:1.06
换手率:1.04%
股息:- -
股息率:- -
每股收益(TTM):-1.0000
每股收益(LYR):-1.0000
净资产收益率:-71.28%
总资产收益率:-27.88%
市净率:0.46
市盈率(LYR):-0.99

数据加载中...

2024/12/23

重要事件披露

Form 8-K - Current report
2024/12/10

重要事件披露

Form 8-K - Current report
2024/11/21

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/01

重要事件披露

Form 8-K - Current report
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/17

重要事件披露

Form 8-K - Current report
2024/04/17

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses